Compounded tirzepatide injections: $219 for a 1-month supply. Start online with licensed provider review and discreet shipping if prescribed. No insurance required.
Provider review required · Available nationwide in all 50 states
New to GLP-1? Read the beginner's guide →
Important: This information is educational only. A licensed provider must evaluate your health history to determine if this prescription treatment is appropriate. Results vary by individual.
The Science
While some options target a single hormone receptor, this medication acts on two. That dual action is designed to set it apart and is why many patients notice meaningful appetite changes.
Designed to help signal fullness to your brain, support slower digestion, and reduce hunger cues. This is the same mechanism used by single-pathway options and it works well on its own.
Activates a second hormone receptor that can enhance the appetite-supporting effect and improve how your body handles glucose. This can be an important difference for eligible patients.
When both pathways are active together, the combined pathway can create a stronger effect for many eligible patients. Some patients report feeling satisfied with smaller portions, experiencing fewer cravings, and noticing progress that they did not see with other approaches.
What to Expect
Weeks 1–2
Many patients notice appetite changes. Some feel the difference within days. Mild adjustment effects are normal as your body adapts to slower digestion.
Weeks 3–6
Weight change often becomes visible. You are likely on your second or third dose level by now. Energy can improve as blood sugar stabilizes. Most people feel fully comfortable with injections.
Weeks 8–12
At or near your therapeutic dose. This is where the dual pathways can deliver their full effect. Your provider assesses progress and fine-tunes your plan.
Month 4+
Many patients are close to their goal by this stage. Maintenance planning begins. Long-term adherence is the key to keeping results.
The Approach
Everyone adjusts differently. Your provider starts low, monitors your response, and increases only when you are ready. No rushing. No guessing.
Intro
Gentle Start
The lowest dose lets your body meet the dual pathways without overwhelm. Some people feel mild appetite changes right away.
Build 1
First Increase
Your provider raises the dose based on your comfort level. Appetite support can deepen. Most adjustment effects fade by now.
Build 2
Second Increase
The GIP pathway can become more active here. Some patients notice accelerated progress at this stage. Energy and satiety can improve.
Target
Full Dose
Both pathways are fully active. This is your therapeutic sweet spot. Your provider checks in regularly to keep you here comfortably.
Dosing is individualized by your licensed provider. Some patients move through stages faster or slower depending on their response, sensitivity, and goals. There is no fixed timeline. Prescription required.
Your Options
Both are effective. The right choice depends on how aggressive your goals are, your budget, and how your body responds.
| Feature | Dual-Action Injection | Weekly Injection |
|---|---|---|
| How often | Once per week | Once per week |
| Hormone pathways | Two (GLP-1 + GIP) | One (GLP-1) |
| Appetite support level | Dual-pathway | Single-pathway |
| Best for | Larger goals, comprehensive approach | First-time users, steady approach |
| Research history | Newer, emerging data | Extensive long-term data |
| Price | $219/month | $169/month |
One flat $219 monthly price is all-inclusive — licensed provider review, your compounded medication if prescribed, and discreet shipping, with no separate membership fees.
Start Tirzepatide Intake“Website is easy to navigate. Good communication. Got my tirzepatide incredibly quick.”
Verified Google review
Common Questions
The dual-action option activates two hormone pathways instead of one. It is designed to target both the primary fullness receptor and a secondary metabolic receptor. The secondary pathway is designed to add an extra layer of appetite support and metabolic improvement, which is why some patients notice changes that are easier to track.
No. Zepbound® and Mounjaro® are FDA-approved brand-name medicines containing tirzepatide. Compounded tirzepatide may be prepared by a licensed pharmacy pursuant to an individual prescription, but it is not a generic version of the brand medicines, and is not represented as bioequivalent, clinically equivalent, or interchangeable.
It is a once-weekly subcutaneous injection that you self-administer at home. Most patients inject into the abdomen, thigh, or upper arm. The process takes about 30 seconds. Your provider will guide you through proper technique.
Many people notice appetite changes within the first week. Weight change often becomes visible within 3 to 6 weeks. Because the dual pathways work together, some patients feel the effects sooner than with single-pathway options. Individual results vary.
Treatment begins at a low dose and increases in stages. This allows your body to adapt comfortably. Your provider monitors your progress and adjusts based on how you tolerate each level. Most patients reach their therapeutic dose within 8 to 12 weeks.
This option may be a strong fit for people with larger weight loss goals, those who have tried other approaches without success, or anyone who wants comprehensive appetite support. It can also be a strong option for people managing blood sugar concerns alongside weight. A licensed provider will determine if it is appropriate for you.
Mild stomach discomfort is the most common experience, especially during the first few weeks or after a dose increase. This is your body adjusting to slower digestion and new hormone signals. It typically subsides. Eating smaller, slower meals and staying well hydrated helps.
Yes, many patients start with the single-pathway option and transition to the dual-action option once they understand how their body responds to this type of therapy. Your provider can help you plan a smooth transition.
Most patients continue on a lower maintenance dose to preserve their results. Stopping completely often leads to rebound hunger and weight regain. Your provider will help you build a sustainable long-term plan that fits your life.
This medication is not appropriate for everyone. During your evaluation, a licensed provider will review your complete health history to determine if this treatment is safe for you.
Not appropriate if you have:
Common experiences include:
This is not a complete list. A full safety review will be conducted by your provider before any prescription is issued. Report any severe or persistent symptoms to your provider immediately.
See if the dual-action program is right for you. Provider review required. Licensed provider review included. Prescription required if approved.
Start Tirzepatide IntakeOne flat $219 monthly price, all-inclusive — licensed provider review, medication if prescribed, and discreet shipping. Nothing to pay unless a provider approves your treatment.